PFIZER INC cotiza a 28.28 USD y tiene una capitalización bursátil de $161.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.77 | $0.75 | $0.66 |
| Estimado | $0.74 | $0.68 | $0.72 | $0.57 |
| Sorpresa | — | +13.2% | +4.2% | +15.8% |
| Métrica | PFE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.3% | 57.0% | +17.3% |
| Operating Margin | — | -38.6% | — |
| Net Margin | 12.4% | -33.6% | +46.0% |
| FCF Margin | 14.5% | -13.9% | +28.4% |
| ROE | 9.0% | -40.4% | +49.4% |
| ROA | 3.7% | -32.0% | +35.7% |
| Current Ratio | 1.16 | 2.84 | -1.68 |
| Debt / Equity | 0.71 | 0.28 | +0.43 |